BRAF and K-ras gene mutations in human pancreatic cancers

Cancer Letters

Volumn 199, Issue 2, 2003, Pages 169-173

  Ishimura, Norihisa ^a   Yamasawa, Kunihiro ^a   Rumi, Mohammad Azharul Karim ^a   Kadowaki, Yasunori ^a   Ishihara, Shunji ^a   Amano, Yuji ^a   Nio, Yoshinori ^a   Higami, Tetsuya ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

BRAF; K ras; Mutation; Pancreatic cancer; Serine threonine kinase

Indexed keywords

B RAF KINASE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CODON; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; PANCREAS CARCINOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0142123412     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00384-7     Document Type: Article

References (12)

1. Peyssonnaux C., Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell. 93:2001;53-62.
2. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:2000;289-305.
3. Andreyev H.J., Norman A.R., Cunningham D., Oates J., Dix B.R., Iacopetta B.J., Young J., Walsh T., Ward R., Hawkins N., Beranek M., Jandik P., Benaouzig R., Jullian E., Laurent-Puig P., Olschwang S., Muller O., Hoffmann I., Rabes H.M., Zietz C., Troungos C., Valavanis C., Yuen S.T., Ho J.W., Croke C.T., O'Donoghue D.P., Giaretti W., Rapallo A., Russo A., Banzan V., Tanaka M., Omura K., Azuma T., Ohkusa T., Fujimori T., Ono Y., Pauly M., Faber C., Glaesener R., de Goeiji A.F., Arends J.W., Anderson S.N., Lovig T., Breivik J., Gaudernack G., Clausen O.P., De Angelis P.D., Meling G.I., Rogum T.O., Smith R., Goh H.S., Font A., Rosell R., Sun X.F., Zhang H., Benhattar J., Losi L., Lee J.Q., Wang S.T., Clarke P.A., Bell S., Quirke P., Bubb V.J., Piris J., Cruickshank N.R., Morton D., Fox J.C., Al-Mulla F., Less N., Hall C.N., Snary D., Wilkinson K., Dillon D., Costa J., Pricolo V.E., Finkelstein S.D., Thebo J.S., Senagore A.J., Halter S.A., Wadler S., Malik S., Krtolica K., Urosevic N. Kirsten ras mutations in patients with colorectal cancer. The 'RASCAL II' study. Br. J. Cancer. 85:2001;692-696.
4. Shirasawa S., Furuse M., Yokoyama N., Sasazuki T. Altered growth of human colorectal cancer cell lines disrupted at activated Ki-ras. Science. 260:1993;85-88.
5. Grunewald K., Lyons J., Frohlich A., Feichtinger H., Weger R.A., Schwab G., Janssen J.W., Bartram C.R. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer. 43:1989;1037-1041.
6. Motojima K., Urano T., Nagata Y., Shiku H., Tsurifune T., Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann. Surg. 217:1993;138-143.
7. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A. Nature. 417:2002;949-954.
8. Sobin L.H., Wittekind C. UICC TNM Classification of Malignant Tumors. 1997;Wiley, New York. pp. 87-90.
9. Song M.M., Nio Y., Dong M., Tamura K., Furuse K., Tian Y.L., He S.G., Shen K. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients. J. Surg. Oncol. 75:2000;176-185.
10. Yuen S.T., Davies H., Chan T.L., Ho J.W., Bignell G.R., Cox C., Stephens P., Edkins S., Tsui W.W., Chan A.S., Futreal P.A., Stratton M.R., Wooster R., Leung S.Y. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 62:2002;6451-6455.
11. Naoki K., Chen T.H., Richards W.G., Sugarbaker D.J., Meyerson M. Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res. 62:2002;7001-7003.
12. Brose M.S., Volpe P., Feldman M., Kumar M., Rishi I., Gerrero R., Einhorn E., Herlyn M., Minna J., Nicholson A., Roth J.A., Albelda S.M., Davies H., Cox C., Brignel G., Stephens P., Futreal P.A., Wooster R., Stratton M.R., Weber B.L. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 62:2002;6997-7000.